{"id":"W2149193049","doi":"10.1016/j.ahj.2013.05.013","title":"Evaluation of the dual peroxisome proliferator–activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: Rationale and design of the AleCardio trial","year":2013,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Diabetes mellitus; Clinical endpoint; Myocardial infarction; Placebo; Acute coronary syndrome; Rosiglitazone; Type 2 Diabetes Mellitus; Type 2 diabetes; Randomized controlled trial; Heart failure; Pioglitazone; Endocrinology; Cardiology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003041206,0.00165091,0.002939212,0.0002818429,0.0004244267,0.001454781,0.0006670404,0.001762146,0.001680703],"category_scores_gemma":[0.002339085,0.0004517798,0.002003924,0.0003501289,0.0009920686,0.0006875101,0.0004484487,0.003530828,0.0005262964],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004973133,"about_ca_system_score_gemma":0.0009796834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003767357,"about_ca_topic_score_gemma":0.001053291,"domain_scores_codex":[0.9987521,0.0006846545,0.00008468169,0.000208324,0.0001058187,0.0001644096],"domain_scores_gemma":[0.9994061,0.0001824983,0.0001084051,0.00006076213,0.00005168282,0.0001905711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.8941324,0.003712205,0.008137053,0.00184285,0.00600462,0.0002167942,0.0001174405,0.001309815,0.01044192,0.00182342,0.002722497,0.06953907],"study_design_scores_gemma":[0.9135609,0.05446218,0.01323569,0.0002770133,0.007316147,0.0002328389,0.00006406576,0.0008747087,0.002513343,0.001563141,0.005842068,0.00005797472],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9420404,0.03202315,0.002424323,0.008153755,0.001709837,0.003461526,0.001440573,0.0001330364,0.008613328],"genre_scores_gemma":[0.9791366,0.007616209,0.002825768,0.003482896,0.00120475,0.002785777,0.0009148588,0.00002911663,0.002003985],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.003041206,"threshold_uncertainty_score":0.01608366,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0142807865465899,"score_gpt":0.2431731210422286,"score_spread":0.2288923344956387,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}